Agios Pharmaceuticals (AGIO) EBT (2012 - 2026)
Agios Pharmaceuticals (AGIO) posted EBT of -$147.8 million for Q1 2026, down 35.49% on a QoQ basis from -$109.1 million in Q4 2025, and down 32.56% year-over-year from -$219.1 million in Q1 2025.
Agios Pharmaceuticals (AGIO) EBT (2012 - 2026) Analysis & Trends
Agios Pharmaceuticals' EBT history runs 15 years deep, the most recent figure standing at -$147.8 million for Q1 2026.
- Quarterly EBT fell 32.56% year-over-year to -$147.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$492.2 million (down 173.06% YoY) and the FY2025 annual result came in at -$413.8 million, down 157.63% from the prior year.
- EBT was -$147.8 million for Q1 2026 at Agios Pharmaceuticals, down from -$109.1 million in the prior quarter.
- Across five years, EBT topped out at $1.0 billion in Q3 2024 and bottomed at -$147.8 million in Q1 2026.
- A 5-year average of -$39.6 million and a median of -$100.3 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2024 — EBT surged 1196.14% — and 2025, when it tumbled 110.33%.
- Agios Pharmaceuticals' EBT stood at -$97.1 million in 2022, then rose by 1.2% to -$95.9 million in 2023, then declined by 9.86% to -$105.4 million in 2024, then decreased by 3.47% to -$109.1 million in 2025, then sank by 35.49% to -$147.8 million in 2026.
- Business Quant data shows AGIO's EBT at -$147.8 million in Q1 2026, -$109.1 million in Q4 2025, and -$103.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | -147.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -147.76 Mn |
| Dec 31, 2025 | -109.06 Mn |
| Sep 30, 2025 | -103.43 Mn |
| Jun 30, 2025 | -131.97 Mn |
| Mar 31, 2025 | -111.47 Mn |
| Dec 31, 2024 | -105.40 Mn |
| Sep 30, 2024 | 1.00 Bn |
| Jun 30, 2024 | -110.50 Mn |
| Mar 31, 2024 | -96.73 Mn |
| Dec 31, 2023 | -95.94 Mn |
| Sep 30, 2023 | -91.32 Mn |
| Jun 30, 2023 | -89.99 Mn |
| Mar 31, 2023 | -87.04 Mn |
| Dec 31, 2022 | -97.11 Mn |
| Sep 30, 2022 | -91.69 Mn |
| Jun 30, 2022 | -100.26 Mn |
| Mar 31, 2022 | -104.23 Mn |
| Dec 31, 2021 | -98.58 Mn |
| Sep 30, 2021 | -84.26 Mn |
| Jun 30, 2021 | -82.79 Mn |